ArticleNeuroimage. Reports2026
A parameterized gamma-variate function can describe the temporal response of cerebral blood flow after Acetazolamide injection in Moyamoya patients.
Article in Neuroimage. Reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Quantitative modelling of the temporal response of cerebral blood flow (CBF) following Acetazolamide (ACZ) may be performed using a parameterized gamma-variate function with physiologically interpretable parameters. When combined with sequential CBF measurement before and after administration of ACZ, such a model could enable assessment of cerebrovascular reserve (CVR) while accounting for regional differences in the timing of the vascular response between steno-occlusive and unaffected territories. To evaluate this approach, we applied the model to patients with moyamoya disease (MMD). Methods: Twenty-four MMD patients underwent MRI including structural- and sequential multi-delay arterial spin labeling acquisitions before and after ACZ injection. Non-linear least squares curve fitting was performed on CBF values extracted from vascular regions. Root mean squared error (RMSE), absolute and relative CVR (CVR Results: Twenty-one patients were evaluated (age range 10-61; 16 females), three was excluded due to technical issues. Median RMSE ranged between 2.8 and 3.8 ml/100 g/min. CVR Conclusion: This parameterized gamma-variate function framework provides physiologically interpretable parameters for modelling the CBF response to ACZ in MMD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.